SL

Shyamsundar Lahu Tilve

Active Director Director DIN 11006330
DIN 11006330 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shyamsundar Lahu Tilve

Data last updated:

Shyamsundar Lahu Tilve is a Director at Mantra Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11006330
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Mar 20252025Active

Board colleagues of Shyamsundar Lahu Tilve

Directorship timeline

Open interactive timeline →
Mantra Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shyamsundar Lahu Tilve

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyamsundar Lahu Tilve

Shyamsundar Lahu Tilve currently holds 1 directorship: Mantra Pharmaceuticals Private Limited (Director, since 18 Mar 2025).

Shyamsundar Lahu Tilve was first appointed on 18 Mar 2025 as Director at Mantra Pharmaceuticals Private Limited.

The current boards of Shyamsundar Lahu Tilve's companies include Ravindra Raghavendra Gandmali (Mantra Pharmaceuticals Private Limited), Shashi Bhushan Singh (Mantra Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available